HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Lack of guidelines, clinical data complicate treatment of rare cancers
-
- AGS-003 improved OS in unfavorable-risk metastatic renal cell carcinoma
- BRCA carriage improved epithelial ovarian cancer survival
- High BMI associated with increased risk for FASN-negative colorectal cancer
- IMRT superior to CRT, possibly to proton beam for prostate cancer
- Lower eGFR associated with increased risk for renal, urothelial cancer
- MDV3100 extended OS, PFS in men with castration-resistant prostate cancer
- Sugar molecules enabled efficient detection of precancerous cells in esophagus
- Younger breast cancer survivors report distress, lower quality of life
-
- A 46-year-old male with advanced nonseminomatous testicular cancer, renal and lung impairment
- Drug importation authorized to ease shortages
- FDA grants priority review for HER-2–positive breast cancer treatment
- FDA issues warning about counterfeit cancer drug
- ODAC rejects expanded use for bone drug in men with prostate cancer
- A 52-year-old female with intravenous leiomyomatosis with intracardiac extension Munir Ghesani, MD, FACNM; Alan Benvenisty, MD; Rangaswamy Chintapatla, MD; Peerapod Chiowanich, MD; Darren Buonocore, MD; Nasima Jafferjee, MD